SI1187612T1 - Use of riluzole for the treatment of multiple sclerosis - Google Patents

Use of riluzole for the treatment of multiple sclerosis

Info

Publication number
SI1187612T1
SI1187612T1 SI200030601T SI200030601T SI1187612T1 SI 1187612 T1 SI1187612 T1 SI 1187612T1 SI 200030601 T SI200030601 T SI 200030601T SI 200030601 T SI200030601 T SI 200030601T SI 1187612 T1 SI1187612 T1 SI 1187612T1
Authority
SI
Slovenia
Prior art keywords
riluzole
treatment
multiple sclerosis
benzothiazolamine
trifluoromethoxy
Prior art date
Application number
SI200030601T
Other languages
English (en)
Slovenian (sl)
Inventor
Chris Polman
Original Assignee
Vereniging Voor Christelijk Wetenschappelijk Onderwijs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vereniging Voor Christelijk Wetenschappelijk Onderwijs filed Critical Vereniging Voor Christelijk Wetenschappelijk Onderwijs
Publication of SI1187612T1 publication Critical patent/SI1187612T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI200030601T 1999-06-04 2000-06-02 Use of riluzole for the treatment of multiple sclerosis SI1187612T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99201788 1999-06-04
US17432800P 2000-01-04 2000-01-04
PCT/IB2000/000933 WO2000074676A1 (en) 1999-06-04 2000-06-02 Use of riluzole for the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
SI1187612T1 true SI1187612T1 (en) 2005-06-30

Family

ID=56290027

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030601T SI1187612T1 (en) 1999-06-04 2000-06-02 Use of riluzole for the treatment of multiple sclerosis

Country Status (11)

Country Link
EP (2) EP1187612B1 (xx)
JP (1) JP2003522121A (xx)
AT (2) ATE287713T1 (xx)
AU (1) AU777537B2 (xx)
CA (1) CA2375874A1 (xx)
DE (1) DE60017733T2 (xx)
ES (1) ES2235896T3 (xx)
NZ (1) NZ515685A (xx)
PT (1) PT1187612E (xx)
SI (1) SI1187612T1 (xx)
WO (1) WO2000074676A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1100504A2 (en) 1998-07-02 2001-05-23 Eisai Co., Ltd. Pharmaceutical compositions and their uses for treatment of demyelinating disorders
US6872739B1 (en) * 1999-06-04 2005-03-29 Vereniging Voor Christelijk Wetenshappelikjk Onderwijs Use of riluzole for the treatment of multiple sclerosis
IL136687A0 (en) * 2000-06-12 2001-06-14 Mor Research Applic Ltd Pharmaceutical composition for the treatment of multiple sclerosis
CA2558380A1 (en) * 2004-03-03 2005-09-15 Teva Pharmaceutical Industries, Ltd. Combination therapy with glatiramer acetate and riluzole
ITMI20061274A1 (it) * 2006-06-30 2008-01-01 Consiglio Nazionale Ricerche Vettori nanoparticellari lipidici contenenti riluzolo e composizioni farmaceutiche che li contengono
EP2228054A1 (en) 2009-03-13 2010-09-15 ITALFARMACO S.p.A. Riluzole aqueous suspensions
WO2010113225A1 (en) * 2009-03-30 2010-10-07 Yutoku Pharmaceutical Industries Co., Ltd. Riluzole-containing transdermal patch
EP3220890A1 (en) * 2014-11-21 2017-09-27 Biohaven Pharmaceutical Holding Company Ltd. Sublingual administration of riluzole
WO2016085998A1 (en) * 2014-11-26 2016-06-02 Medicinova, Inc. Combination of ibudilast and riluzole and methods of using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688138B1 (fr) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
AU7298196A (en) * 1995-10-25 1997-05-15 Janssen Pharmaceutica N.V. Infusions of neuroprotectants and perfluorochemicals
DE69629838T2 (de) * 1995-11-15 2004-07-08 Yamanouchi Pharmaceutical Co., Ltd. Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate
US5728728A (en) * 1996-04-10 1998-03-17 Kozachuk; Walter E. Methods of providing neuroprotection
IL119989A0 (en) * 1997-01-10 1997-04-15 Yeda Res & Dev Pharmaceutical compositions for oral treatment of multiple sclerosis
US6872739B1 (en) * 1999-06-04 2005-03-29 Vereniging Voor Christelijk Wetenshappelikjk Onderwijs Use of riluzole for the treatment of multiple sclerosis

Also Published As

Publication number Publication date
PT1187612E (pt) 2005-05-31
AU777537B2 (en) 2004-10-21
EP1552831B1 (en) 2009-01-07
AU5421900A (en) 2000-12-28
EP1187612A1 (en) 2002-03-20
ATE287713T1 (de) 2005-02-15
NZ515685A (en) 2002-12-20
ATE419851T1 (de) 2009-01-15
WO2000074676A1 (en) 2000-12-14
EP1552831A1 (en) 2005-07-13
JP2003522121A (ja) 2003-07-22
ES2235896T3 (es) 2005-07-16
DE60017733D1 (de) 2005-03-03
CA2375874A1 (en) 2000-12-14
EP1187612B1 (en) 2005-01-26
DE60017733T2 (de) 2006-01-12

Similar Documents

Publication Publication Date Title
HK1150153A1 (en) Use of pramipexole to treat amyotrophic lateral sclerosis
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
TWI256389B (en) Novel hPPAR delta agonists and pharmaceutical compositions comprising the same
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2212299A (en) Compositions and methods for the treatment of tumor
HK1040944A1 (en) Methods and compositions for the prevention and treatment of anemia
MXPA03007816A (es) Calzoncillo desechable y metodo para proporcionar el mismo.
IL158867A0 (en) Ostepontin and agonists thereof in treatment and/or prevention of neurological diseases
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
HK1076049A1 (en) Use of riluzole for treating multiple sclerosis
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
SI1187612T1 (en) Use of riluzole for the treatment of multiple sclerosis
IL143212A0 (en) Compositions and methods for the treatment of tumor
EP0681787A3 (en) Use of an enzyme for the manufacture of an agent suitable for the treatment and / or prophylaxis of coccidiosis.
ZA98420B (en) Use of pramipexole in the treatment of restless legs syndrome.
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
AU2002365621A1 (en) Composition for treating the surface of the skin
AU2001273759A1 (en) Essential oils and chemically related species for the treatment of increased bone resorption
AU2002363228A1 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
HK1064947A1 (en) Use of non-feminizing estrogens as retinoprotecti ve agents for the treatment of glaucoma
ZA986090B (en) Agents for the prevention and/or treatment of radiation-induced disorders
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain